Arintra
Arintra Raises $25M Series B for Healthcare Revenue Assurance
Arintra announced $25M in Series B financing on August 26, 2026. Arintra raised a $25 million Series B led by Define Ventures, bringing total funding to $51 million for its autonomous medical-coding platform.
Round details
The financing includes backing from Define Ventures, Peak XV Partners, Yale New Haven Health Center for Health Care Innovation, Endeavor Health Ventures. The company did not publish a valuation with the announcement.
- Round: Series B
- Capital announced: $25M
- Total funding reported: $51M
- Headquarters: San Francisco, CA
How the company plans to use the capital
Arintra will expand its enterprise revenue-assurance platform across more specialties and care settings as health systems automate coding, claims quality, and revenue-cycle workflows.
Why this matters for GTM teams
The round demonstrates buyer interest in AI systems tied directly to measurable healthcare revenue outcomes, especially where customers also participate as strategic investors.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Arintra Series B announcement.
Company Info
Investors (4)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started